UCB Partners with Veeva to Transform Customer Engagement with Vault CRM

UCB Embraces Innovation with Veeva Vault CRM

In a significant move to enhance customer engagement in the life sciences sector, UCB, a global biopharmaceutical company, has announced its decision to implement Veeva Vault CRM, a leading agent-based engagement platform. This strategic partnership aims to streamline operations and improve the customer experience through advanced, industry-specific artificial intelligence (AI).

Edwin Erckens, UCB's Chief Digital Technology Officer, expressed enthusiasm about this transition, stating, "We are excited to strengthen our strategic partnership with Veeva through the adoption of Vault CRM. Our shared dedication to customer success is key, and this new platform will provide UCB with the technological foundation essential to advance commercial execution."

Empowering Commercial Strategy

Vault CRM is uniquely designed to support the specific needs of the biopharmaceutical industry. According to Chris Moore, President of Veeva Europe, this platform will offer UCB a reliable, scalable, and future-ready technology base that is crucial for moving forward with UCB's commercial strategies. He remarked, "Together with UCB, we will support the company in this critical initiative."

Utilizing state-of-the-art technology, Vault CRM is part of the broader Vault CRM Suite, which serves as the technological backbone for what is termed 'Agentic Commercial'. Among its innovative features, the Agentic Call Report function generates 'Commercial Evidence' that helps identify previously hidden barriers to treatment, enabling UCB to better serve its customers and ultimately improve patient outcomes.

A Commitment to Innovation

Veeva Systems is known for its dedication to innovation and product quality in the biotechnology sector. With a customer base that includes more than 1,500 clients, from leading global pharmaceutical companies to emerging biotech firms, Veeva is committed to aligning the interests of all stakeholders involved, including customers, employees, and shareholders.

Veeva seeks to leverage its expertise to ensure that UCB can utilize the full potential of Vault CRM to enhance its operations. As a Public Benefit Corporation, Veeva focuses on sustainable growth by ensuring that the needs of the community and the industry are met while maintaining a high standard of service.

This partnership highlights the ongoing evolution in the biopharmaceutical industry, where leveraging advanced technology can lead to enhanced engagement strategies, ultimately laying the groundwork for improved patient care. The commitment from UCB and Veeva to prioritize technological advancement underscores the vital role that customer engagement will play in shaping the future of healthcare.

Looking Ahead

As the biopharmaceutical landscape continues to develop, UCB's strategic decision to embrace Veeva Vault CRM is expected to yield significant benefits, ensuring they remain at the forefront of industry innovation. With Veeva's proven track record and UCB's dedication to customer-centric approaches, both companies are poised to make remarkable strides in the realm of patient and customer engagement.

For more information about Veeva Systems and its innovative solutions for the life sciences industry, visit veeva.com.